Morgan Stanley is close to an agreement to buy around €900 million ($940 million) in Spanish mortgages from Banco Santander ...

Morgan Stanley has upgraded PTC Therapeutics (PTCT), while downgrading Immuneering (IMRX) and Amicus Therapeutics (FOLD).

Morgan Stanley kept Apple as its "Top Pick" for 2025 as the bank sees the tech giant's artificial intelligence (AI) product ...

Joby Aviation's strategic investments and cash reserves, despite recent stock price volatility, position the company for ...

The stock's fall snapped a two-day winning streak.

Sempra (NYSE:SRE) +1.5% in Friday's trading as Morgan Stanley upgrades to Overweight from Equal Weight with a $98 price ...

After back-to-back years of more than 20% returns for the S&P 500, what's in store for 2025? Most on Wall Street say more ...

Import prices edged up 0.1% last month after a downwardly revised 0.1% rise in October, the Labor Department's Bureau of ...

Broadcom's (AVGO) quarterly results may have topped estimates, but its guidance of up to $90B in revenue from custom AI chips ...

Shares of Broadcom popped more than 21% Friday, pushing the company’s market cap beyond $1 trillion for the first time.

Fintel reports that on December 13, 2024, Morgan Stanley upgraded their outlook for PTC Therapeutics (NasdaqGS:PTCT) from ...

Funds managed by Igneo Infrastructure Partners are buying out Morgan Stanley’s 50% stake in Norwegian liquefied natural gas ...